Kerala Ayurveda Ltd.

320.00 +4.30 ▲1.4%

27 February 2024, 04:01:00 PM
Volume: 23,283

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.keralaayurveda.biz
Market Cap 385.04 Cr.
Enterprise Value(EV) 453.73 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -0.92 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 41.67 Trailing Twelve Months Ending 2023-12
Book Value / Share 24.74 Trailing Twelve Months Ending 2023-12
Price to Book Value 12.93 Calculated using Price: 320.00
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.20 Cr. 12,032,451 Shares
FaceValue 10
About Kerala Ayurveda Ltd.
Kerala Ayurveda Ltd. (KAL) was founded on the banks of river Periyar at Aluva, Kochi, Kerala in 1945 by Late Vaidyan K G K Panicker, the renowned Ayurvedacharya. He was a doyen in Ayurvedic system, a visionary and a mentor. Now, more than half a century later, his inspired creation epitomizes all that is modern and state-of-the-art in Ayurveda. A leading Ayurvedic company today, KAL is backed by advanced technology and highly qualified dedicated staff.

Kerala Ayurveda Ltd. Delivery

Delivered Qty
Traded Qty

Kerala Ayurveda Ltd. Performance

1 Day
+1.36%
1 Week
+15.15%
1 Month
+15.52%
3 Month
+32.01%
6 Month
+165.01%
1 Year
+246.51%
2 Year
+376.90%
5 Year
+406.73%
10 Year
+1291.30%

Kerala Ayurveda Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 0 0 862.54 38.72 43.39 93.9 -183.03 137.66 -14.76
Return on Capital Employed (%) 8.35 9.15 8.91 8.88 7.64 9.27 -0.45 12.62 6.26
Return on Assets (%) 3.72 3.81 4.27 3.14 2.59 4.15 -4.47 2.14 -0.38

Kerala Ayurveda Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds -9 -6 7 8 4 8 3 6 6 5
Non Curr. Liab. 53 53 24 48 59 63 67 42 55 63
Curr. Liab. 25 24 48 45 28 31 42 60 52 48
Minority Int. 1 1 1 2 2 2 2 2 2 2
Equity & Liab. 71 73 81 103 92 103 114 110 114 119
Non Curr. Assets 57 59 59 61 64 67 67 70 77 80
Curr. Assets 14 14 22 42 28 33 44 37 34 39
Misc. Exp. not W/O 3 3 3 3
Total Assets 71 73 81 103 92 103 114 110 114 119

Kerala Ayurveda Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 39 46 50 56 62 77 62 80 93 100
Other Income 0 1 0 0 1 0 0 0 0 1
Total Income 39 46 51 56 63 77 62 81 94 101
Total Expenditure -33 -39 -43 -48 -57 -69 -61 -71 -91 -96
PBIDT 6 8 7 8 5 7 1 10 3 5
Interest -2 -2 -1 -2 -3 -2 -6 -7 -5 -4
Depreciation -1 -2 -2 -2 -1 -1 -1 -1 -1 -1
Taxation -1 -1 -1 -1 -1 0 2 0 0 0
Exceptional Items 1 1 3 1
PAT 3 3 3 3 3 4 -5 2 0 -1
Minority Interest 0 0 0 0 0 0 0 0 0
Share Associate
Other Related Items 0
Consolidated Net Profit 2 3 3 3 2 4 -5 2 -1 -1
Adjusted EPS 2 3 3 3 2 4 -5 2 -1 -1

Kerala Ayurveda Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 6 4 -10 12 5 7 -1 10
Cash Fr. Inv. -1 0 -3 -3 -3 -3 -4 -1 -2 -7
Cash Fr. Finan. 1 2 -3 0 17 -12 1 6 -13 -2
Net Change -1 2 0 1 4 -2 2 12 -16 0
Cash & Cash Eqvt 1 2 2 3 7 5 6 19 3 3

Kerala Ayurveda Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 61.52 61.52 61.52 61.52 61.52 61.52 61.52 61.52 63.44
Public 38.48 38.48 38.48 38.48 38.48 38.48 38.48 38.48 36.56
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 100.00 100.00 100.00 0.00 100.00 100.00 46.55 8.09 7.45

Kerala Ayurveda Ltd. Announcements

Thu, 15 Feb 2024
News Paper Publications
News Paper publication - results for the quarter ended 31st December 2023
Wed, 14 Feb 2024
Outcome Of Board Held On 14/2/2024
Outcome of the Board held on 14th Feb 24 alongwith Standalone and Consolidated financials for the quarter ended 31st December 23 and Press Release
Tue, 06 Feb 2024
Board Meeting Intimation for Considering And Approving The Financial Results For The Quarter Ended 31St December 2023.
KERALA AYURVEDA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve the unaudited financial results for the quarter ended 31st December 2023.

Kerala Ayurveda Ltd. Technical Scans

Mon, 26 Feb 2024
Close Crossing Last Week High Close Crossing Last Week High
Opening at High Opening at High
Opening at Low Opening at Low
Closing Above Previous High Closing Above Previous High
Closing Above Previous High For 3 Days Closing Above Previous High For 3 Days

Kerala Ayurveda Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 373,564.46 1,579.10 +1.4%
Cipla Ltd. 118,662.53 1,488.95 +1.3%
Dr. Reddy's Laboratories Ltd. 107,402.65 6,441.20 +0.0%
Zydus Lifesciences Ltd. 95,410.36 942.50 0.0%
Divi's Laboratories Ltd. 94,984.66 3,537.95 -1.1%
Apollo Hospitals Enterprise Ltd. 94,585.14 6,615.05 +0.6%
Torrent Pharmaceuticals Ltd. 88,769.16 2,618.00 -0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.94 1,579.10 +1.4%
Cipla Ltd. Consolidated 2023-12 32.00 1,488.95 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.54 6,441.20 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.08 942.50 0.0%
Divi's Laboratories Ltd. Consolidated 2023-12 68.68 3,537.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 119.83 6,615.05 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.42 2,618.00 -0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.99 1,579.10 +1.4%
Cipla Ltd. Consolidated 2023-12 4.58 1,488.95 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 4.00 6,441.20 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.91 942.50 0.0%
Divi's Laboratories Ltd. Consolidated 2023-12 7.29 3,537.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.00 6,615.05 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.41 2,618.00 -0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,579.10 +1.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,488.95 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,441.20 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 942.50 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,537.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,615.05 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,618.00 -0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,579.10 +1.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,488.95 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,441.20 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 942.50 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,537.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,615.05 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,618.00 -0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,579.10 +1.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,488.95 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,441.20 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 942.50 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,537.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,615.05 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,618.00 -0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,579.10 +1.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,488.95 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,441.20 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 942.50 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,537.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,615.05 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,618.00 -0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,579.10 +1.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,488.95 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,441.20 +0.0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 942.50 0.0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,537.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,615.05 +0.6%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,618.00 -0.2%

Kerala Ayurveda Ltd. FAQ's

What is Kerala Ayurveda share price?

Can I buy Kerala Ayurveda shares now?

What is the Market Cap of Kerala Ayurveda?

What are the key metrics to analyse Kerala Ayurveda?

What is the 52 Week High and Low of Kerala Ayurveda?

What is the trend of Kerala Ayurveda share price?